|
Cost Effective – Time Effective –
In your Conference Room or Office
Validation and Change Control:
The Validation Life Cycle
Conducted by Gamal Amer, PhD
Principal - Premier Compliance Services, Inc.
May 16, 2008
This seminar
presents an overview of validation and change control as they pertain to
pharmaceuticals manufacturing. Dr. Amer will review the general validation
approach, define what is meant by a validated state, and identify the need
for having a change control system and procedure in place. He will define
what a change control system entails and propose an outline of a robust
change control procedure. The concept of validation life-cycle will also be
introduced and its meaning discussed at length. The importance of change
control in maintaining the validated state and closing the validation cycle
will be discussed.
Managing changes in pharmaceuticals manufacturing through implementing a
change control procedure is a regulatory requirement. Manufacturers of drug
products are required to maintain the operations in a validated state and to
have a change control system in place. This seminar is aimed at introducing
the concept of a validated state and managing change within the validation
life cycle. Dr. Amer will draw on his vast experience in the pharmaceutical
industry to explain the concepts and provide many real life examples to
support these concepts.
In this
unique web seminar format, lasting just one hour, you will be able to follow
along with a PowerPoint presentation, ask questions, and interact
with Dr. Amer. An outline of this seminar and Dr. Amer’s qualifications
can be found below.
Validation and Change Control: The Validation Life Cycle
|
Part I Validation and Change
Control
-
What is meant by validation and its confirmatory nature
-
How validation is conducted
-
The validated states and the importance of maintaining them
-
The Validation Life Cycle
-
The types of change and their potential impact on the validated
state
-
What a change control system entails and its importance
-
What a robust change control system and procedure may look like
and entail
|
|
Part II Questions and Answers
|
Register now!
Don’t like to order online?
Call us at 714-289-1233
All registrations include handout materials. Once you’re registered, you will
receive via e-mail (the e-mail address you provide in your registration) the web location to download the handout materials.
We accept Visa, MasterCard, and
American Express (AMEX). All prices are in US
dollars.
Note International shipments: If ordering the CD for shipment,
additional shipping charges will be added for all international shipments.
Note: Our shopping cart is set to
the highest security level. Please make sure that the address
corresponds to the credit card holder. It may result in a declined
order if the address doesn't match the address on file for the
cardholder named on the credit card.
Please enter your billing information
EXACTLY as it appears on
your credit card statement.
Get the CD and handout
GMP080516E - CD and
Handout materials
Validation and
Change Control: The Validation Life Cycle
CD price includes all HANDOUT MATERIALS and audio
CD. CD will be shipped three weeks after the seminar |
$397.00 |
 |
Instructor
Gamal Amer, Ph.D.
Gamal Amer, Ph. D. is
Principal at Premier Compliance Services, Inc.; Management Consultants for
compliance and manufacturing operations performance in the life sciences
industry. He holds a Ph. D. in Chemical Engineering and has over two decades
experience in the Pharmaceutical and related industries. He has held
positions of increased responsibility with leading pharmaceutical, consumer
product and engineering consulting firms over the years. His experience
includes comprehensive process design in bulk pharmaceutical manufacturing,
biotechnology manufacturing, pharmaceutical solid dosage manufacturing and
containment of potent and radioactive therapeutics. He is also experienced
with facility development for therapeutic products operations.
Dr. Amer is a recognized
expert in GMP compliance and validation. He has consulted for many of the
leading pharmaceutical, biotechnology and medical device manufacturers. He
has lectured extensively in the US, Europe, Asia and the Middle East, taught
many courses, and authored many papers which were published in peer reviewed
publication. He is a member of ISPE, PDA, ACS and AIChE.
Please forward this to your colleagues who may be
interested.
|